Rare lephants
Screener

Arbutus Biopharma Corporation

ABUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 22, 2026 FORM 8-K
SCHEDULE 13G/A Oct 7, 2026
4 Oct 7, 2026 FORM 4
4 Oct 7, 2026 FORM 4
4 Oct 7, 2026 FORM 4
4 Oct 7, 2026 FORM 4
SCHEDULE 13D/A Oct 5, 2026
4 Oct 5, 2026 FORM 4
SC TO-I/A Oct 1, 2026 SC TO-I/A
SC TO-I/A Sep 30, 2026 SC TO-I/A
4 Sep 23, 2026 FORM 4
4 Sep 23, 2026 FORM 4
4 Sep 23, 2026 FORM 4
4 Sep 23, 2026 FORM 4
SCHEDULE 13G Sep 4, 2026
SC TO-I Aug 24, 2026 SC TO-I
SC TO-C Aug 21, 2026 SC TO-C
8-K Aug 21, 2026 FORM 8-K
SCHEDULE 13G/A Aug 12, 2026
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 FORM 8-K
8-K Jul 16, 2026 FORM 8-K
4 Jun 10, 2026 FORM 4
4 Jun 10, 2026 FORM 4
S-8 Jun 5, 2026 S-8
← Newer Page 1 of 42 · 1047 filings Older →